STK15/Aurora-A Expression in Primary Breast Tumors Is Correlated with Nuclear Grade but Not with Prognosis

Cancer

Volumn 100, Issue 1, 2004, Pages 12-19

  Royce, Melanie E ^a   Xia, Weiya ^a   Sahin, Aysegul A ^a   Katayama, Hiroshi ^a   Johnston, Dennis A ^a   Hortobagyi, Gabriel ^a   Sen, Subrata ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AIK1; Aurora A; Breast carcinoma; BTAK

Indexed keywords

AURORA A KINASE; GENE PRODUCT; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CELL NUCLEUS; CELL TYPE; CHROMOSOME 20Q; CORRELATION ANALYSIS; FEMALE; GENE; GENE AMPLIFICATION; GENE MAPPING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STK15 GENE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 20; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RETROSPECTIVE STUDIES;

EID: 0346217067     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11879     Document Type: Article

References (34)

1. Isola JJ, Kallioniemi OP, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol. 1995;147:905-911.
2. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 1997;14:2195-2200.
3. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 1994;54:4257-4260.
4. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res. 1995;1:1455-1461.
5. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Independent amplification and frequent co-amplification of three non-syntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 1996;56:3441-3445.
6. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001;2:21-32.
7. Francisco L, Wang W, Chan CS. Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol. 1994;14:4731-4740.
8. Glover DM, Leibowitz MH, McLean DA, Parry H. Mutations in aurora prevent centrosome separation, leading to the formation of monopolar spindles. Cell. 1995;81:95-105.
9. Chan CS, Botstein D. Isolation and characterization of chromosome-gain and increase- in-ploidy mutants in yeast. Genetics. 1993;135:677-691.
10. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998;17:3052-3065.
11. Zhou H, Kuang J, Zhong L, et al. Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189-193.
12. Sen S, Shou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst. 2002;94:1320-1329.
13. Tanaka T, Kimura M, Matsunaga K, Fukada D, Mori H, Okano Y. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res. 1999;59:2041-2044.
14. Miyoshi Y, Iwao K, Egawa C, Noguchi S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int J Cancer. 2001;92:370-373.
15. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
16. Shackney SE, Shankey TV. Common patterns of genetic evolution in human solid tumors. Cytometry. 1997;29:1-27.
17. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991;51:3075-3079.
18. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997;386:623-627.
19. Pihan GA, Purohit A, Wallace J, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998;58:3974-3985.
20. Kimura M, Kotani S, Hattori T, et al. Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, AIK, related to aurora of Drosophila and yeast Ip11. J Biol Chem. 1997;272:13766-13771.
21. Roghi C, Giet R, Uzbekov R, et al. The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J Cell Sci. 1998;111:557-572.
22. Muleris M, Salmon RJ, Dutrillauz AM, et al. Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors. Cancer Genet Cytogenet. 1987;29:289-301.
23. Kallioneimi A, Kallioniemi OP, Piper J, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A. 1994;91:2156-2160.
24. James LA, Mitchell EL, Menasce L, Varley JM. Comparative genomic hybridization of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene. 1997;14:1059-1065.
25. Reznikoff CA, Belair CD, Yeager TR, et al. A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol. 1996;23:571-584.
26. Courjal F, Cuny M, Rodriguez C, et al. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer. 1996;74:1984-1989.
27. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res. 2000;6:1833-1839.
28. -/- cells. EMBO J. 2002;21:483-492.
29. Shin SO, Lee KH, Kim JH, et al. Alternative splicing in 5′-untranslated region of STK15 gene, encoding centrosome associated kinase, in breast cancer cell lines. Exp Mol Med. 2000;32:193-196.
30. Pauletti G, Dandekar S, Rong H, et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol. 2000;18:3651-3664.
31. Kakar S, Puangsuvan N, Stevens JM, et al. HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: comparison of results and correlation with survival. Mol Diagn. 2000;5:199-207.
32. Ridolfi RL, Jamehdor MR, Arber JM. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach. Mod Pathol. 2000;13:866-873.
33. Wang S, Saboorian MH, Frenkel E, Hynan L, Gokaslan ST, Ashfaq R. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridization assays. J Clin Pathol. 2000;53:374-381.
34. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of Aurora-A are early events in rat mammary carcinogenesis. Cancer Res. 2002;62:4115-4122.